DK0481744T3 - Piperazinderivater - Google Patents

Piperazinderivater

Info

Publication number
DK0481744T3
DK0481744T3 DK91309513.9T DK91309513T DK0481744T3 DK 0481744 T3 DK0481744 T3 DK 0481744T3 DK 91309513 T DK91309513 T DK 91309513T DK 0481744 T3 DK0481744 T3 DK 0481744T3
Authority
DK
Denmark
Prior art keywords
piperazine
rsqbstr
lsqbstr
phenylbutyryl
azepin
Prior art date
Application number
DK91309513.9T
Other languages
English (en)
Inventor
Ian Anthony Cliffe
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Application granted granted Critical
Publication of DK0481744T3 publication Critical patent/DK0481744T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Indole Compounds (AREA)
DK91309513.9T 1990-10-19 1991-10-16 Piperazinderivater DK0481744T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909022820A GB9022820D0 (en) 1990-10-19 1990-10-19 Piperazine derivatives

Publications (1)

Publication Number Publication Date
DK0481744T3 true DK0481744T3 (da) 1996-10-07

Family

ID=10684053

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91309513.9T DK0481744T3 (da) 1990-10-19 1991-10-16 Piperazinderivater

Country Status (15)

Country Link
EP (1) EP0481744B1 (da)
JP (1) JP3007203B2 (da)
KR (1) KR100193928B1 (da)
AT (1) ATE143012T1 (da)
AU (1) AU642044B2 (da)
CA (1) CA2053709C (da)
DE (1) DE69122205T2 (da)
DK (1) DK0481744T3 (da)
ES (1) ES2091879T3 (da)
GB (2) GB9022820D0 (da)
GR (1) GR3021221T3 (da)
HU (2) HU212943B (da)
IE (1) IE65379B1 (da)
NZ (1) NZ240271A (da)
PT (1) PT99251B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125900D0 (en) * 1991-12-05 1992-02-05 Wyeth John & Brother Ltd Piperazine derivatives
FI950486A0 (fi) * 1992-08-05 1995-02-03 Wyeth John & Brother Ltd Amidijohdannaiset
GB9221931D0 (en) * 1992-10-17 1992-12-02 Wyeth John & Brother Ltd Piperazine derivatives
GB2271930B (en) * 1992-11-03 1996-07-24 Wyeth John & Brother Ltd Pharmaceutical piperazine derivatives
GB9223153D0 (en) * 1992-11-05 1992-12-16 Wyeth John & Brother Ltd Piperazine derivatives
GB9303968D0 (en) * 1993-02-26 1993-04-14 Wyeth John & Brother Ltd 5-ht1a ligands
GB9304632D0 (en) * 1993-03-06 1993-04-21 Wyeth John & Brother Ltd Amide derivatives
US5609849A (en) * 1994-03-11 1997-03-11 The Trustees Of The University Of Pennsylvania Serotonin (5-HT1A) receptor ligands and imaging agents
GB9419024D0 (en) * 1994-09-21 1994-11-09 Wyeth John & Brother Ltd Bicyclic carboxamides
GB9525239D0 (en) * 1995-12-09 1996-02-07 American Home Prod Medical treatment
FR2744448B1 (fr) * 1996-02-02 1998-04-24 Pf Medicament Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
ITMI20021327A1 (it) * 2002-06-14 2003-12-15 Recordati Chem Pharm Nuove ossialchilpiperazine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2776282A (en) * 1954-05-04 1957-01-01 Searle & Co Cyclic amides of alpha-toluic acids and derivatives thereof
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
KR0173310B1 (ko) * 1989-04-22 1999-02-01 폴 에이 리쳐 피페라진 유도체
AU644488B2 (en) * 1990-10-19 1993-12-09 John Wyeth & Brother Limited Piperazine derivatives

Also Published As

Publication number Publication date
PT99251A (pt) 1992-08-31
IE65379B1 (en) 1995-10-18
GR3021221T3 (en) 1997-01-31
HU211587A9 (en) 1995-12-28
KR920008019A (ko) 1992-05-27
KR100193928B1 (ko) 1999-06-15
GB9022820D0 (en) 1990-12-05
HU913292D0 (en) 1992-01-28
DE69122205D1 (de) 1996-10-24
GB2248836A (en) 1992-04-22
DE69122205T2 (de) 1997-01-30
AU642044B2 (en) 1993-10-07
GB2248836B (en) 1994-05-04
JP3007203B2 (ja) 2000-02-07
CA2053709A1 (en) 1992-04-20
EP0481744B1 (en) 1996-09-18
NZ240271A (en) 1993-03-26
HUT60264A (en) 1992-08-28
GB9118744D0 (en) 1991-10-16
JPH04282371A (ja) 1992-10-07
IE913669A1 (en) 1992-04-22
EP0481744A1 (en) 1992-04-22
CA2053709C (en) 2001-12-11
AU8592091A (en) 1992-04-30
ES2091879T3 (es) 1996-11-16
ATE143012T1 (de) 1996-10-15
PT99251B (pt) 1999-04-30
HU212943B (en) 1996-12-30

Similar Documents

Publication Publication Date Title
NL193283B (nl) 4,4-Dialkyl-1-[4-[4-(2-pirimidinyl)-1-piperazinyl]-butyl]-2,6- piperazinedionen.
DK0481744T3 (da) Piperazinderivater
FI960364A7 (fi) Uusia 1,4-(difenyylialkyyli)piperatsiinijohdoksia
NO304071B1 (no) Heterocyklisk-cykliske amin-derivater
ATE138921T1 (de) Xanthinderivate
ATE113282T1 (de) Heteroaryl piperazine als antipsychotische mittel.
DE69106388D1 (de) Antipsychotische 4-(1,2-benzisoazolyl)piperidinderivate.
ATE213943T1 (de) Verwendung von piperazin-acetamid-derivaten gegen reperfusionsschaden
NO903640L (no) Fremgangsmaate for fremstilling av 2-(rs)-substituerte 2,3-dihydro-5-oksy-4,6,7-trimetylbenzofuraner.
ITMI911520A1 (it) Derivati di piperidina, loro preparazione e uso
NZ216750A (en) Morpholino derivatives and fungicides
ATE92469T1 (de) Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung.
DE69211639D1 (de) Neue verbindungen und deren medizinale verwendung
MX9205186A (es) Derivados de 4-[4-[4-(4-hidroxifenil)-1-piperazinil]-fenil]-5-metil-3h-1,2,4-triazo l-3-ona
MY110446A (en) Piperazine derivatives
FI870925L (fi) 4-(2-pyrimidinyl)-1-piperazinyl -heterocykliska karbonylderivater.
MX9201297A (es) Derivados piperacinicos y procedimiento para su preparacion.
DE69523346D1 (de) Substituierte 6-h-1,3,4-thiadiazin-2-amine, deren verwendung als anaesthetisierende cardiovaskulare und hypometabole mittel, und eine sie enthaltende pharmazeutische zubereitung
ATE151736T1 (de) 2-arylpropensäuren und ihre verwendung bei der herstellung von s-ketoprofen
ATE148449T1 (de) Neue verwendung von (s) amino-2-dichloro-3,4- benzyl)-2-propanol-1 enantiomere derivate
FI920945L (fi) Menetelmä terapeuttisesti käyttökelpoisen 2,3,4,5,6,7-heksahydro-1-(4- 1-/4-(2-metoksifenyyli)piperatsinyyli/ -2-fenyylibutyryyli)-1H-atsepiinin tai sen farmaseuttisesti hyväksyttävän happoadditiosuolan valmis tamiseksi